Regulation by neuroprotective factors of NMDA receptor mediated nitric oxide synthesis in the brain and retina.
Akaike
A
A
Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
Tamura
Y
Y
Terada
K
K
Nakata
N
N
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002478:Cells, Cultured; D002766:Cholecystokinin / Q000494:pharmacology / Q000627:therapeutic use; D004298:Dopamine / Q000494:pharmacology / Q000627:therapeutic use; D005136:Eye Proteins / Q000378:metabolism; D051379:Mice; D008959:Models, Neurological; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors; D009419:Nerve Tissue Proteins / Q000378:metabolism; D009498:Neurotoxins / Q000633:toxicity; D009569:Nitric Oxide / Q000096:biosynthesis*; D010084:Oxidation-Reduction; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects* / Q000378:metabolism; D012160:Retina / Q000187:drug effects* / Q000378:metabolism
D005136:Eye Proteins; D009419:Nerve Tissue Proteins; D009498:Neurotoxins; D016194:Receptors, N-Methyl-D-Aspartate; D009569:Nitric Oxide; D016202:N-Methylaspartate; D002766:Cholecystokinin; D002118:Calcium; D004298:Dopamine